IRB Company, Inc. (IRBCo), an independent review board that protects the rights and well-being of research volunteers participating in human research, announces its Full Accreditation status by the Association for the Accreditation of Human Research Protection Programs (AAHRPP).
Accreditation by AAHRPP offers assurances to research participants, researchers, sponsors, government regulators and the general public that IRBCo is focused on excellence in its human research protection programs.
"IRBCo has dedicated itself to remaining at the forefront of human research protections, and this voluntary process to earn accreditation required us to examine and review our operations and functions so that we remain a leading provider of central independent review board services," said Anil Sharma, MD, MBA, CIP, the Medical Director and Chief Executive Officer of IRBCo. "Accreditation validates our comprehensive program, which integrates ethical reviews, state-of-the-art technology and staff development."
As an independent, non-profit accrediting body, AAHRPP uses a voluntary, peer-driven educational model to ensure that human research protection programs meet rigorous standards for quality and protection. To earn accreditation, organizations must provide evidence, through policies, procedures and practices, of their commitment to scientifically and ethically sound research and to continuous improvement.
Telemedicine Considerations When Conducting Decentralized Clinical Trials
January 14th 2025Compliance with state telemedicine requirements is imperative, as not only will most clinical trial sponsors contractually require such compliance, but non-compliance may also subject the practitioner to licensure violations and liability.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.